Article info
PDFNeurological Dilemmas
First-line Treatment in Parkinson’s Disease
Citation
First-line Treatment in Parkinson’s Disease
Publication history
- First published June 1, 2005.
Online issue publication
February 01, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2005 BMJ
Other content recommended for you
- Occurrence, mortality and cost of brain disorders in Denmark: a population-based cohort study
- Present and future drug treatment for Parkinson’s disease
- Economic burden of low physical activity and high sedentary behaviour in Finland
- Economic burden from smoking-related diseases in Thailand
- How do multiple long-term conditions impact on the cost-of-illness in early rheumatoid arthritis?
- Economic burden of tobacco use in Pakistan
- Good-quality social care for people with Parkinson’s disease: a qualitative study
- Excess costs of type 2 diabetes and their sociodemographic and clinical determinants: a cross-sectional study using data from the German Health Interview and Examination Survey for Adults (DEGS1)
- Cost of ambulatory care of diabetes mellitus: a study from north India
- The economic impact of neurological illness on the health and wealth of the nation and of individuals